首页> 外国专利> vaccine compositions for amoebiasis control based on entamoeba histolytica 112 kda surface protein

vaccine compositions for amoebiasis control based on entamoeba histolytica 112 kda surface protein

机译:溶组织阿米巴112 kda表面蛋白的阿米巴病控制疫苗组合物

摘要

"AMEBASE CONTROL VACCINE COMPOSITIONS BASED ON ENTAMOEBA HISTOLYTICA 112 kDA SURFACE PROTEIN". The present invention relates to the field of immunology, specifically with vaccine compositions for the control of Entamoeba histolytica infections. The compositions according to the present invention have as active principle a 112 kDa amoebic surface protein which is encoded by two genes, one encoding a cysteine protease activity polypeptide and the other one having adhesin activity. The present invention also includes formulations which include the genes encoding said protein which are administered as a DNA vaccine, as well as formulations with the purified proteins or fragments thereof, giving a protective synergistic effect with the combination. These formulations may be administered for prophylactic and therapeutic purposes to combat amoebic infection produced by the protozoan parasite Entamoeba histolytica.
机译:“基于ENTAMOEBA HISTOLYTICA 112 kDA表面蛋白的AMEBASE控制疫苗组合物”。本发明涉及免疫学领域,特别是涉及用于控制溶组织性变形杆菌的疫苗组合物。根据本发明的组合物具有112kDa的阿米巴表面蛋白作为活性成分,其由两个基因编码,一个基因编码半胱氨酸蛋白酶活性多肽,另一个基因具有粘附素活性。本发明还包括以DNA疫苗形式施用的包含编码所述蛋白质的基因的制剂,以及具有纯化的蛋白质或其片段的制剂,从而对组合产生保护协同作用。可以出于预防和治疗目的施用这些制剂,以对抗由原生动物寄生虫组织解脂变形虫产生的阿米巴感染。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号